Research output per year
Research output per year
Search results
-
2021
Trial in progress: Combination of the dual RAF/MEK inhibitor VS-6766 with the mTOR inhibitor everolimus with expansion in patients with KRAS mutant NSCLC
Manickavasagar, T., Stavraka, C., anam, K., Coma, S., Chowdhury, S., Pachter, J., Parker, T., Parmar, M., Finneran, L., Hall, E., Spicer, J., Minchom, A. & Banerji, U., 2021, Trial in progress: Combination of the dual RAF/MEK inhibitor VS-6766 with the mTOR inhibitor everolimus with expansion in patients with KRAS mutant NSCLC.Research output: Chapter in Book/Report/Conference proceeding › Conference paper